MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with B

Bosutinib

Bosutinib 100mg tablets

No stability information

Stability notes for Bosutinib 100mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Bosutinib 100mg tablets
Bosulif 100mg tablets (Pfizer Ltd)
Bosutinib 100mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Bosutinib 100mg tablets (Pfizer Ltd)
Bosutinib 100mg tablets (Thornton & Ross Ltd)
Bosutinib 100mg tablets (Zentiva Pharma UK Ltd)

Bosutinib 400mg tablets

No stability information

Stability notes for Bosutinib 400mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Bosutinib 400mg tablets
Bosulif 400mg tablets (Pfizer Ltd)
Bosutinib 400mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Bosutinib 400mg tablets (Pfizer Ltd)
Bosutinib 400mg tablets (Thornton & Ross Ltd)
Bosutinib 400mg tablets (Zentiva Pharma UK Ltd)

Bosutinib 500mg tablets

No stability information

Stability notes for Bosutinib 500mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Bosutinib 500mg tablets
Bosulif 500mg tablets (Pfizer Ltd)
Bosutinib 500mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Bosutinib 500mg tablets (Pfizer Ltd)
Bosutinib 500mg tablets (Thornton & Ross Ltd)
Bosutinib 500mg tablets (Zentiva Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.